Enable your JavaScript to use Numstock


Numstock » AERI

AERI Stock Analysis

The latest metrics for Aerie Pharmaceuticals, Inc

Value

Metric Target Value
Price / Earnings Ratio < 12.0 -4.28
Price / Book Value Ratio < 1.5 4.86
Price / Sales Ratio < 2.0 16.78
PEG Ratio < 1.0 0.0
EV / EBITDA Ratio < 8.0 -4.65
Price / FCF Ratio Last Year < 15.0 -3.85
Price / FCF Ratio Last Quarter < 15.0 -22.54
Price / TBV Ratio Last Year < 0.7 4.07
Price / TBV Ratio Last Quarter < 0.7 4.75
Price / NCAV Ratio Last Year < 0.7 5.7
Price / NCAV Ratio Last Quarter < 0.7 7.85

Efficiency

Metric Target Value
ROE Last Year > 25.0% -128
ROE Last Quarter > 25.0% -27.07
ROA Last Year > 15.0% -81.59
ROA Last Quarter > 15.0% -10.31
ROTA Last Year > 20.0% -43.77
ROTA Last Quarter > 20.0% -9.04
ROIC Last Year > 20.0% -663.1
ROIC Last Quarter > 20.0% -23.76
ROCE Last Year > 20.0% -89.53
ROCE Last Quarter > 20.0% -10.11
Inventory Turnover Last Year > 4.0 2.69
Inventory Turnover Last Quarter > 4.0 0.54
Pre-tax Margin Last Year > 20.0% -1217
Pre-tax Margin Last Quarter > 20.0% -337.2
Accounts Payable Turnover Last Year > 3.0 2.19
Accounts Payable Turnover Last Quarter > 3.0 0.69
Accounts Receivable Turnover Last Year > 5.0 10.01
Accounts Receivable Turnover Last Quarter > 5.0 2.91

Health

Metric Target Value
Current Ratio Last Year > 1.5 4.34
Current Ratio Last Quarter > 1.5 7.81
Quick Ratio Last Year > 1.5 4.14
Quick Ratio Last Quarter > 1.5 7.52
Flow Ratio Last Year < 1.25 0.34
Flow Ratio Last Quarter < 1.25 2.91
Debt / Equity Ratio Last Year < 0.5 0.0
Debt / Equity Ratio Last Quarter < 0.5 0.88
Debt / EBITDA Ratio Last Year < 4.0 0.0
Debt / EBITDA Ratio Last Quarter < 4.0 -0.92
Debt / NCAV Ratio Last Year < 2.0 0.0
Debt / NCAV Ratio Last Quarter < 2.0 1.45
Long-term Debt / Working Capital Ratio Last Year < 2.0 0.0
Long-term Debt / Working Capital Ratio Last Quarter < 2.0 0.53
Interest Coverage Ratio Ratio Last Year > 8.0 82.87
Interest Coverage Ratio Last Quarter > 8.0 6.56
FCF / Sales Ratio Last Year > 8.0% -760.5
FCF / Sales Ratio Last Quarter > 8.0% -210.3

Growth

Metric Target Value
Earnings Yield > 12% -23.39
Ebit Yield Last Year > 12% -24.75
Ebit Yield Last Quarter > 12% -4.27
FCF Yield Last Year > 10% -18.52
FCF Yield Last Quarter > 10% -3.93
Forward P/E to Trailing P/E Ratio > 1.1 0.0
Operating Cash Flow / EPS Ratio Last Year > 1.2 0.7
Operating Cash Flow / EPS Ratio Last Quarter > 1.2 0.16

Dividends

Metric Target Value
Dividend Yield > 2.0% 0.0
FCF / Dividends Paid Ratio Last Year > 2.5 0.0
FCF / Dividends Paid Ratio Last Quarter > 2.5 0.0
EPS / Dividends Paid Last Year > 2.5 0.0
EPS / Dividends Paid Last Quarter > 2.5 0.0
Payout Ratio < 40.0% 0.0

Ratings

Metric Target Value
Altman Z-score Last Year ≥ 3.5 -3.1
Altman Z-score Last Quarter ≥ 3.5 -0.61